Cushman & Wakefield reports rents at $47.62 per square foot, $138 million in sales volume and a surge in renewals despite elevated vacancy...
ByThe RegistryFebruary 16, 2026The pioneering life science REIT posts its fifth consecutive quarterly loss while accelerating asset sales to shore up balance sheet Alexandria Real Estate...
ByThe RegistryJanuary 28, 2026The Eastside office market closed 2025 with $106.4 million in investment sales across six transactions totaling 386,121 square feet, according to Broderick Group’s...
ByThe RegistryJanuary 6, 2026A Bothell office property leased to BASIS Independent school has changed hands for $45.6 million, or about $317 per square foot, according to...
ByThe RegistryDecember 23, 2025Quarterly loss and major asset write-downs signal ongoing challenges for pioneering life science REIT Alexandria Real Estate Equities reported its fourth consecutive quarterly...
ByThe RegistryOctober 28, 2025Two-tower project at 1445 120th Avenue NE receives environmental approval as part of larger Pine Forest campus transformation The shift from traditional office...
ByThe RegistryOctober 16, 2025Life sciences landlord exits historic Sodo property; Puget Properties affiliate steps in as buyer A Seattle office building has been purchased at a...
ByThe RegistrySeptember 25, 2025A string of facility closures and workforce cuts threatens the Seattle suburb’s ambitions to become a major biotech center The signs of distress...
ByThe RegistryAugust 28, 2025Alexandria Real Estate Equities reported a net loss of $0.64 per share for Q2 2025, marking its third consecutive quarterly loss amid declining...
ByThe RegistryJuly 21, 2025University cites budget constraints and market shifts as $252 million Brightwork building is scrapped The University of Washington has pulled the plug on...
ByThe RegistryJune 30, 2025Alexandria Real Estate Equities (ARE), a pure-play life science REIT, reported its Q1 2025 earnings on April 29th with mixed results that suggest...
ByThe RegistryMay 14, 2025Alexandria Real Estate Equities, Inc. (NYSE: ARE) is executing an ambitious disposition strategy in 2025 as it faces headwinds in the life science...
ByThe RegistryMay 1, 2025
Signup for news and special announcements!
You have successfully joined our subscriber list.